TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14821 · Jun 11

#typescript#editor#gfm#javascript#markdown#markdown_editor#milkdown#prosemirror#remarkjs#rich_text_editor#typescript#wysiwyg#wysiwyg_editor Milkdown is a flexible, open-source editor that lets you write and edit Markdown in a simple, visual way, just like you see it in apps such as Typora. It is built using powerful tools like ProseMirror and Remark, and everything in Milkdown works as a plugin, so you can add or remove features easily. You can customize its look and feel to match your app, and it supports real-time collaboration for team editing. This means you get a reliable, easy-to-use editor that fits your needs and grows with your projects, making writing and sharing documents smoother and more efficient[1][2][4]. https://github.com/Milkdown/milkdown

Results

3 similar posts found

Search: #clinicalstage

当前筛选 #clinicalstage清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #3534 · 12/20/2024, 09:31 AM

$2.16M Fundraising by Umecrine Umecrine Cognition, a Swedish clinical-stage pharmaceutical firm, has raised $2.16 million to advance its innovative drug development targeting neurological disorders. The funding round took place on December 19, 2024. #UmecrineCognition#Pharmaceuticals#NeurologicalDisorders#Funding#Healthcare#ClinicalStage#Sweden

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3412 · 12/18/2024, 12:11 PM

$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform